Adam Friedman, MD, FAAD, is an Associate Professor of Dermatology and serves as Residency Program Director and Director of Translational Research in the Department of Dermatology at the George Washington University School of Medicine and Health Sciences.
Dr. Friedman completed his undergraduate training at the University of Pennsylvania and graduated with Distinction in Dermatologic Research at the Albert Einstein College of Medicine in New York. He completed his internship at New York Hospital Queens and returned to Einstein for his dermatology residency and was appointed chief resident during his final year.
Dr. Friedman joined the Einstein faculty after graduation from 2010-2015, during which time he was the Director of Dermatologic Research, Director of the Translational Research Fellowship and the Associate Program Director. Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation and correcting vascular dysfunction. In line with his research interests, he serves as Vice President of the Nanodermatology Society. Dr. Friedman was recently appointed as President of the Dermatology Section of the New York Academy of Medicine.
Dr. Friedman is also committed to resident and medical education. He chaired the leadership workgroup of the American Academy of Dermatology Resident/Fellows Committee, currently serves on the Sulzberger Committee on Education and is the Senior Editor of the Dermatology In-Review Online Workshop. Dr. Friedman serves as the Dermatology Expert for healthguru.com and publishes a column on Everyday Health entitled “The Skin You’re In.”
Urticaria: Diagnosis and Treatment Considerations
This lecture will highlight the common condition many do not appropriately know how to manage.
- Review how to recognize urticaria and formulate appropriate workups
- New advances in dermatologic treatment
- Availability of new medication(s) or indication(s)
- Advances in medical knowledge
- Evidence-Based Diagnosis & Treatment of Chronic Urticaria/Angioedema. All & Asth Proc. 2014;35(1):10-16.
- The Diagnosis and Management of Acute and Chronic Urticaria, 2014 Update, JACI. 2014;133(3):1270-77.
Core Competencies: 1, 2, 3, 6
Disclosures: Speaker for Janssen Biotech, Inc.; Consultant for Galderma, Encore, Pfizer